Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Race Oncology Ltd. ( (AU:RAC) ) has issued an update.
Race Oncology Ltd has announced the quotation of 1,425 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of May 22, 2025. This move is part of the company’s ongoing efforts to enhance its market presence and provide liquidity for its stakeholders, potentially impacting its operational dynamics and industry positioning.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies.
Average Trading Volume: 141,613
Technical Sentiment Signal: Buy
Current Market Cap: A$245M
See more insights into RAC stock on TipRanks’ Stock Analysis page.